As more biotech animals become available for commercialization, it is critical that prospective marketers be able to navigate the regulatory, intellectual property, public relations and distribution channel obstacles that will undoubtedly stand in their way. This panel will include presentations from the first company to legally commercialize a biotech animal, as well as presentations from several other companies that are extremely close to marketing their own biotech animal products.



Objectives:

Identify key regulatory, intellectual property, public relations and distribution channel challenges.

Describe winning strategies for navigating commercialization obstacles and avoiding common mistakes.

Help prospective marketers understand the broader industry and political dynamics that will affect them.